Regulation And Legal
Aurobindo Pharma Receives US FDA Tofacitinib Approval
Aurobindo Pharma received final US FDA approval to manufacture and market Tofacitinib Tablets, 5 mg and 10 mg.
The product addresses a US market with estimated size of approximately $494 million based
